Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Patent
1991-03-22
1992-07-21
Shippen, Michael L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
435106, 43524031, 514565, C07C24100
Patent
active
051324539
ABSTRACT:
Physiologically active N.sup.6 -(hydrazinoiminomethyl)lysine or pharmaceutically acceptable acid addition salt thereof is administered in a nitric oxide sythesis inhibiting amount to a subject in need of such inhibition (e.g., a subject with low blood pressure, e.g., due to sepsis or to therapeutic administration of cytokines, or needing immunosuppressive effect) or is added to a medium containing isolated organs, intact cells, cell homogenates or tissue homogenates in an amount sufficient to inhibit nitric oxide formation to elucide or control the biosynthesis, metabolism or physiological role of nitric oxide. Compared to known nitric oxide synthesis inhibitors, N.sup.6 -(hydrazinoiminomethyl)lysine and its acid addition salts show a greater relative activity toward inducible isoform of nitric oxide synthase than toward constitutive isoform of nitric oxide synthase. N.sup.6 -(hydrazinoiminomethyl)lysine and its pharmaceutically acceptable acid addition salts are substantially less toxic than are N.sup.G -amionoarginine and its pharmaceutically acceptable acid addition salts.
REFERENCES:
patent: 4282217 (1981-08-01), Baglioni
patent: 4698442 (1987-10-01), Nestor et al.
patent: 5028627 (1991-07-01), Kilbourn
patent: 5059712 (1991-10-01), Griffith
Fukuto, Biochem. Biophys. Res. Commun., 168 pp. 458-465.
Fasehun, O. A., et al., J. Pharmacol. Exp. Ther. 255, 1348-1358 (1990).
Greenstein, J. P., et al., Chemistry of Amino Acids, vol. 3, pp. 1850-1853, John Wiley & Sons, Inc., 1961.
Kilbourn, R., et al., (1990), in "Nitric Oxide from L-Arginine: A Bioregulatory System" (S. Moncada and E. A. Higgs, eds, pp. 61-67, Elsevier Science Publishers, Amsterdam).
Aisaka, K., et al., Biochemical and Biophysic Research Communications, vol. 160, No. 2, pp. 881-886, 4/28/89.
Iyengar, R., et al., Proc. Natl. Acad. Sci., U.S.A., vol. 84, pp. 6369-6373.
Palmer, R. M. J., et al., Nature (London), 333, pp. 664-666, 1988.
Rees, D. D., et al., Proc. Natl. Acad. Sci. U.S.A., vol. 86, pp. 3375-3378, 5/89.
Palmer, R. M. J., et al., Biochem and Biophysical Research Communications, 153, No. 3, 1251-1256 (6/88).
Steuhr, D. J., et al., The Journal of Immunology, 139, No. 2, 518-525, (1987).
Schmidt, H. H. H. W., et al., European Journal of Pharmacology, 154, 213-216, (1988).
Steuhr, D. J., et al., J. Exp. Med. vol. 169, pp. 1011-1020 (Mar. 1989).
Stuehr, D. J., et al., J. Biochem. and Biophysical Research Communications, vol. 161, No. 2, pp. 420-426 (6/15/89).
Turan, A., et al., Acta Chimica Academiae Scientiarum Hungaricae, Tomus 85 (3), pp. 327-332 (1975).
Kilbourn, R. G., et al., Proc. Natl. Acad. Sci. U.S.A. vol. 87, pp. 3629-3632, 5/90.
Sakuma, I., et al., Proc. Natl. Acad. Sci. U.S.A. vol. 85, pp. 8664-8667, 11/88.
Gross, S. S., et al., Biochemical and Biophysical Research Communications, vol. 170, No. 1, pp. 96-103, 7/16/90.
Natanson, C., et al., Journal of Exp. Med. 169:823-832 (1989).
Hibbs, J. B., et al., Biochem. Biophys. Res. Commun. 157:87-94(1988).
Marletta, M. A., et al., Biochemistry 27:8706-8711 (1988).
Palmer, R. M. J., et al., Nature 327:524-526 (1987).
Cornell Research Foundation Inc.
Shippen Michael L.
LandOfFree
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844790